Outcome after autologous stem cell transplantation for myeloma in patients beyond 60, 65 and 70 years of age: A retrospective Analysis from the German Registry for Stem Cell Transplantation (DRST)

Maximilian Merz,Hans-Juergen Salwender,Katja Weisel,Christof Scheid,Hermann Einsele,N Kröger,Dietrich W. Beelen,Peter Dreger, H. Goldschmidt

Clinical Lymphoma, Myeloma & Leukemia（2015）

引用 0|浏览21

暂无评分

摘要

Multiple myeloma (MM) is most frequently diagnosed among patients aged 65-74. Autologous stem cell transplantation (ASCT) is considered as standard of care for patients younger than 65 years but limited data are available on outcome of ASCT for patients beyond 65 years.

查看译文

关键词

autologous stem cell transplantation,stem cell transplantation,myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要